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orphanmemberof thenuclear receptor superfamily that inter-
actswith peroxisomeproliferator-activated receptorc coacti-
vator-1a (PGC-1a) to stimulate vascular endothelial growth
factor (VEGF) expression and angiogenesis in a hypoxia-
inducible factor-1a-independent pathway. Although it is not
regulated by any natural ligand, the action of ERRa can be
blocked by the synthetic molecule XCT790. In the present
study, Sprague–Dawley rats were randomly allocated to a
sham group, injury-saline group or injury-XCT90 group. A
modiﬁed Allen’s weight-drop method was applied to induce
the acute traumatic spinal cord injury (SCI) model in these
rats, and an injection of XCT790 was administered every
24 h, starting half an hour after the SCI contusion. Histo-
logical analyses revealed thatXCT790signiﬁcantly aggravated
tissue damage and decreased the number of ERRa-positive
cells at 1, 3 and7 daysafter SCI.Westernblot andquantitative
real-timepolymerasechain reaction (qRT-PCR) analysesalso
indicated that XCT790 dramatically repressed the expression
of ERRa, thus reducing the expression of VEGF and
angiopoietin-2 (Ang-2) throughout the duration of the experi-
ment, but the expression of PGC-1a was not aﬀected.
Immunoﬂuorescence analyses indicated that vascular densi-
ty and endothelial cell proliferation were decreased in the
injury-XCT90 group compared with the injury-saline group.
These results suggest that ERRa is involved in mediating
angiogenesis after SCI in the rat traumatic SCI model.
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570INTRODUCTION
Spinal cord injury (SCI) is the most devastating injury
responsible for motor and sensory dysfunction, and it
can progress to severe paraplegia and/or complications
in patients. The complex pathological processes of SCI
involve the original injury, a secondary lesion and spinal
restoration (Amar and Levy, 1999). The primary assault
causes immediate vascular disruptions at the injury epi-
center (Ng et al., 2011). Subsequently, a cascade of injury
responses, including astrocyte reactivity and hematoge-
nous immune cell migration, can contribute to ischemia,
necrosis, edema, apoptosis and cavitation, which then
in turn contribute to further secondary damage that exac-
erbates the neurological deﬁcits (Bazley et al., 2012).
It has long been understood that trauma to the spinal
cord disrupts its local vasculature, resulting in petechial
hemorrhage observed at the injury epicenter immediately
after injury (Dray et al., 2009). Angiogenesis, the formation
of new blood vessels from pre-existing vasculature, can
serve to reduce the secondary damage after SCI, protect-
ing against ischemia by increasing oxygen delivery and
nutrients to sites of regeneration and removing metabolic
waste (Lutton et al., 2012). Therefore, the vascular
response to SCI and the molecular elements that regulate
angiogenesis are critical components of SCI and repair.
Angiogenesis is a complex process in which hypoxia-
inducible factor (HIF), vascular endothelial growth factor
(VEGF) and angiopoietin-2 (Ang-2) are the critical ones.
VEGF plays a pivotal role in the regulation of
vasculogenesis, angiogenesis, remodeling, and vascular
leakage under both physiological and pathological
conditions (Distler et al., 2003). Activated VEGF and its
receptors increase blood vessel density; restore blood
ﬂow; and promote neuronal survival, axonal regeneration
and functional recovery after SCI (Long et al., 2012).
Ang-2 appears to be an important signaling molecule dur-
ing vascular remodeling, causing both increases and
decreases in the microvascular density (Dore-Duﬀy and
LaManna, 2007). In the presence of VEGF, the application
of Ang-2 mediates an increase in capillary diameter,
induces migration and proliferation of endothelial cells
and stimulates the sprouting of new blood vessels. How-
ever, without suﬃcient VEGF, exposure to Ang-2 causes
capillaries to undergo apoptotic regression (Pichiule and
LaManna, 2002).ons.org/licenses/by-nc-nd/4.0/).
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one of the ﬁrst identiﬁed orphan nuclear receptors that
is important in the regulation of energy metabolism
genes (Villena and Kralli, 2008). Similar to other transcrip-
tional-binding sites, such as HRE (HIF response ele-
ment), ERRa can activate the VEGF promoter directly
through an estrogen receptor response element (ERRE)
(Arany et al., 2008). As a regulator of oxidative metabo-
lism, ERRa activity drives increased aerobic ATP produc-
tion, which may support the high metabolic rate that
characterizes highly proliferative cells while also increas-
ing the cellular oxygen requirement (Stein et al., 2009).
Although the expression of ERRa alone has low constitu-
tive activity on the VEGF promoter region containing the-
se elements, coexpression of the coactivator peroxisome
proliferator-activated receptor gamma coactivator-1a
(PGC-1a), strongly drives VEGF transcription (Stein
et al., 2009). PGC-1a is a transcriptional co-activator that
powerfully regulates cellular energy metabolism in mito-
chondria-rich tissues with high oxidative capacity through
coactivation of the transcription factor ERRa on con-
served binding sites found both in the promoter and a nov-
el conserved enhancer located in the ﬁrst intron of the
VEGF gene (Arany et al., 2008; Shoag and Arany,
2010). Although regulation of VEGF through PI3Kinase/
AKT and HIF is considered the classical pathway under
ischemic conditions, a pathway involving ERRa and
PGC-1a was recently discovered to be independent of
HIF (Arany et al., 2008; Stein et al., 2008).
Although it is not regulated by any natural ligand,
ERRa can be deactivated by the synthetic molecule
XCT790. XCT790, which was identiﬁed as an ERRa-
speciﬁc ligand and acts as an inverse agonist, not only
represses the transcriptional eﬀects of ERRa but also
disrupts the interaction between ERRa and PGC-1a
(Willy et al., 2004; Lanvin et al., 2007; Teyssier et al.,
2008). XCT790 does not interfere with a speciﬁc
proliferation-inducing pathway, allowing it to modulate
the proliferation of any type of cells/tissues expressing
ERRa (Bianco et al., 2009).
Our previous study suggested that HIF-1a/VEGF is
involved in angiogenesis after rat SCI. However,
whether ERRa also regulates angiogenesis in the
traumatized SCI model remains unknown. In the present
study, ERRa was investigated for its eﬀects on PGC-
1a, VEGF and Ang-2 expression, as well as vascular
density and endothelial cell proliferation, in an
experimental rat model of traumatic SCI by injecting
animals with the inverse agonist XCT790.EXPERIMENTAL PROCEDURES
Experimental SCI model
A total of 140 adult male Sprague–Dawley rats (200–
250 g in weight) were randomly assigned into three
groups: (1) sham group (n= 20); (2) injury-saline group
(n= 60); and (3) injury-XCT90 group (n= 60). Each
injury group was then sub-divided into three time-period
sub-groups: 1, 3 and 7 days (n= 20 in each sub-group,
n= 5 for each of the techniques). The animals were
housed individually at a constant temperature on a 12-hlight/dark cycle with free unlimited food and water. All
animal care and experimental procedures were
performed in accordance with protocols approved by the
Laboratory Animal Users Committee at the Xiangya
Hospital, Central South University, Changsha, China.
All animals were anesthetized using 10% chloral
hydrate administered at 3 mg/kg intraperitoneally, and
operated on under aseptic conditions. Next, a 15-mm
midline skin incision was made at the thoracic region
(T8–T13). A laminectomy was performed at vertebral
level T10, exposing the dorsal cord surface with the dura
remaining intact. The exposed spinal cord segment
(approximately 3 mm in length) of the injury-saline group
and the injury-XCT90 group was subjected to a moderate
contusive SCI using a modiﬁed Allen’s weight-drop
apparatus as described previously (Chen et al., 2010). Fol-
lowing surgery, all animals were injected with penicillin G
(4 wu, i.m.) once a day in both hindlimbs for 5 days, and
their bladders were manually massaged twice daily.
XCT790 (Tocris Bioscience, Bristol, UK) was prepared in
10 mM dimethyl sulfoxide (DMSO) with gentle warming,
and then the solution was diluted to 1% with saline. In the
injury-XCT90 group, the animals underwent a laminectomy
plus traumatic SCI operation and then were injected with
XCT790 intraperitoneally (0.48 mg/kg) at 30 min post-
surgery and once a day until sacriﬁce. In the injury-saline
and sham groups, the animals were subjected to similar
treatment consisting of an equivalent volume of sterile
saline.
Histological examination and immunohistochemical
(IHC) analysis
The animals were anesthetized via an intraperitoneal
injection of 10% chloral hydrate (300 mg/kg) and
sacriﬁced by transcardial perfusion with heparinized
saline for 20 min, followed by ﬁxing with 4%
paraformaldehyde in 0.1 M phosphate-buﬀered saline
(PBS), pH 7.4. The spinal tissue spanning the injury
epicenter with 5 mm of adjacent rostral and caudal
segments was dissected from the spinal column, post-
ﬁxed overnight at 4 C in 4% paraformaldehyde, and then
embedded in paraﬃn. Paraﬃn sections with a 4-lm
thickness were stained with hematoxylin and eosin for
histological assessment and placed onto charged-glass
microscope slides for IHC staining. After
deparaﬃnization, antigen retrieval and endogenous
peroxidase inactivation, the slides were incubated
overnight at 4 C with an anti-ERRa antibody (1:200
Santa Cruz Biotechnology, Santa Cruz, CA, USA) and
2% bovine serum albumin (BSA) or with PBS as a
negative control for the IHC staining study. The sections
were then washed and incubated with a goat anti-rabbit
antibody (ready-to-use Dako REAL EnVision/HRP,
Danmark) for 50 min at room temperature (RT). Finally,
the sections were incubated in DAB-containing Substrate
Working Solution (Dako K500711, Danmark) for 10 min,
rinsed in dH2O, counterstained with hematoxylin,
dehydrated, and placed in mounting medium. All the
sections were observed under a digital camera (Leica
DM4000B, Germany) (50 magniﬁcation). The
transverse sections with the severest injury were
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(Media Cybernetics, Silver Springs, MD, USA) software,
the cavity areas were outlined and quantiﬁed. Sections of
the injury epicenter were analyzed and the ratio for
‘‘cavity area/total area’’ from each section determined.
For quantitative analysis of the number of positive cells,
two sections from the lesion epicenter of each specimen
were randomly selected and three random images in the
anterior horn of gray matter visual ﬁelds of each slice
were obtained under digital camera (200 magniﬁcation).
Dark brown-colored neuronal cells were scored as
positive for the stain and blindly counted by two examiners.Immunoﬂuorescence
The animals were sacriﬁced and perfused as described
above. The dissected tissues were ﬁxed in 4%
paraformaldehyde in PBS (pH 7.4) for 3 h and
maintained overnight in 6% sucrose/PBS, rinsed with
acetone, and embedded in optimal cutting temperature
compound (OCT) (Sakura Finetek USA, Inc., Torrance,
CA, USA). The samples were stored at 80 C until
they were sectioned (10 lm), and the slides were stored
at 20 C. When ready, the slides were thawed at RT
for 20 min, washed with PBS for 10 min, and blocked
with 10% goat serum diluted in PBS for 1 h. The slides
were then probed with a mouse monoclonal RECA-1
antibody (1:200; Abcam plc, Cambridge, UK) or rabbit
monoclonal PCNA antibody (1:200; Abcam) diluted in
3% goat serum in PBS overnight at 4 C, followed by
incubation with the secondary antibodies, Alexa Fluor
488 goat anti-rabbit IgG (H + L) (1:1000, Jackson, West
Grove, PA, USA) and Cy3 goat anti-mouse IgG (H + L)
(1:1000, Jackson, USA), diluted in 3% goat serum for
30 min at RT. The sections were washed with PBS
followed by counterstaining with 4’,6-diamidino-2-
phenylindole (DAPI), and then mounted using an
antifade mounting medium. Visual ﬁelds in the anterior
horn of gray matter were obtained using a Leica
DM4000B camera (200 magniﬁcation). Two sections
from the lesion epicenter of each specimen and three
ﬁelds per slide were selected at random. The evaluator
was blinded to the treatments received and counted the
number of RECA-1 label (red) and RECA-1/PCNA/DAPI
merged label (white) manually.Western blot
A1-cmsegment of spinal cord encompassing the injury site
was harvested and immediately frozen in liquid nitrogen
and stored at 80 C until further processing. The frozen
spinal cord was lysed by radio immunoprecipitation assay
(RIPA) lysis buﬀer (50 mM Tris (pH 7.4), 150 mM NaCl,
1% Triton X-100, 1% sodium deoxycholate, 0.1% SDS,
1 mM sodium orthovanadate, 2 mM sodium ﬂuoride,
1 mM EDTA, 0.5 lg/ml leupeptin, 0.7 lg/ml Pepstatin A,
50 lg/ml PMSF, 2.2 lg/ml Aprotinin), and protein
concentrations were determined using a Bradford protein
assay (Wellbio, Changsha, China). Forty micrograms of
proteins were loaded and separated by SDS gel
electrophoresis, and then transferred to PVDF
membranes (Millipore, Mississauga, Canada). Themembranes were blocked in 5% skimmed milk in Tris-
buﬀered saline with 0.1% Tween (TBS-T) for 1 h at RT.
The membranes were then incubated overnight at 4 C
with a rabbit-anti-ERRa antibody (1:500; Sigma–Aldrich,
St. Louis, MO, USA), rabbit-anti-PGC-1a antibody
(1:500; Santa Cruz Biotechnology), mouse-anti-VEGF
antibody (1:200, Abcam) and rabbit-anti-Ang-2 antibody
(1:500, Abcam), followed by incubation with horseradish
peroxidase (HRP)-conjugated secondary antibodies, goat
anti-rabbit IgG (H + L) (1:3000, cwbiotech, China) or
goat anti-mouse IgG (H + L) (1:3000, cwbiotech, China)
for 1 h at RT. Immunoreactive protein bands were
visualized using an enhanced chemiluminescence
detection system (Super Signal ECL Kit, Thermo
Scientiﬁc, IL, USA). The relative intensities were
determined using Quantity One 4.6.2 software (Bio-Rad,
Hercules, CA, USA), and b-actin was used as the internal
control.
Quantitative real-time polymerase chain reaction
(qRT-PCR)
Total RNA from 10-mm long spinal cord segments
containing the injury epicenter was extracted with TRIzol
(Invitrogen, Carlsbad, CA, USA) according to the
manufacturer’s instructions. Single-stranded cDNA was
synthesized from a total of 3-lg RNA using the
RevertAid First Strand cDNA Synthesis Kit (Thermo
Fisher Scientiﬁc, Pittsburgh, PA, USA) and qRT-PCR
was performed using SYBGREEN PCR Master Mix
(Applied Biosystems, Foster City, CA, USA). Tm was
determined in accordance with the speciﬁcity of the
melting curve after ampliﬁcation. The following primers,
designed and synthesized by GenScript Inc., were used
with annealing temperatures of 60 C:
ERRa:
Forward: AAGCCCTGATGGACACCTC
Reverse: GAAGCCTGGGATGCTCTTG
PGC-1a:
Forward: TGGAGCAATAAAGCAAAGAGC
Reverse: GTGTGAGGAGGGTCATCGTT
VEGF:
Forward: CTTGAGTTGGGAGGAGGATG
Reverse: TGGCAGGCAAACAGACTTC
Ang-2:
Forward: GCAAGCATACAGGAGGGTCT
Reverse: ATCAAAGTGGACAGGCAAGC
b-actin:
Forward: CATCCTGCGTCTGGACCTGG
Reverse: TAATGTCACGCACGATTTCC
The PCR reaction was performed in an ABI 7500
Real-Time PCR thermocycler (Applied Biosystems,
Foster City, CA, USA). Analyses of gene expression
were performed using the 2DDCt method. Agarose gel
electrophoresis showed that PCR products migrated to
the expected position, validating the speciﬁcity of the
primers used in the qRT-PCR (data not shown).Statistical analysis
Statistical analysis was performed using the SPSS 17.0
software package (SPSS Inc., Chicago, IL, USA). Data
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contrast was analyzed by Student’s t test for comparison
in the cavity area between the injury-XCT790 group and
the injury-saline group. For other data, the signiﬁcance
between groups was evaluated using a one-way analysis
of variance (ANOVA) followed by a Newman–Keuls post
hoc test. P< 0.05 was interpreted as statistically
signiﬁcant during the mean diﬀerence analysis.
RESULTS
XCT790 inhibited ERRa expression and aggravated
tissue damage in the injured spinal cord
Compared with the outcomes in the injury-saline and
sham groups, a distinct histopathological appearance
was observed 3 days post-surgery in the injury-XCT790
group. Many normal neurons were observed in the gray
matter ventral horn of the uninjured (sham) spinal cord
with no sign of cellular destruction (Fig. 1A). A series of
histopathological changes to the spinal cord, such as
inﬂammatory cell inﬁltration, hemorrhage and
vacuolation, and fewer normal neurons were observedFig. 1. Eﬀects of XCT790 on the histopathological features and ERRa expres
and immunohistochemical analyses at 1, 3 and 7 days after SCI. (A–F) R
diﬀerences in histopathological analysis and ERRa expression among the
3 days post-injury (A&D: Sham group; B&E: injury-saline group; C&F: injury-X
the number of cells expressing ERRa among the three groups. i arrow: inﬂam
results are expressed as mean ± SD of ﬁve animals per group. Signiﬁcan
evaluated using the ANOVA followed by the Newman–Keuls post hoc test (⁄p
injury-saline group). Scale bar = 100 lm.in the injury-XCT790 group (Fig. 1C) compared with the
injury-saline group (Fig. 1B). Besides, the cavity areas
were increased in the injury-XCT790 group compared
with the injury-saline group at the injury epicenter 7 days
post-surgery (Fig. 2).
Brown-colored ERRa molecules were observed in the
nuclei of many cells of the uninjured spinal cord gray
matter (Fig. 1D). Fewer ERRa-positive cells were
observed at 1, 3 and 7 days after SCI (Fig. 1G). Both
the injury-XCT790 and injury-saline groups exhibited a
similar change tendency in ERRa expression, with the
highest levels of ERRa observed on day 3 after
traumatic SCI (Fig. 1E, F). However, XCT790 injection
signiﬁcantly repressed the release of ERRa at 1, 3 and
7 days post-injury (Fig. 1G). In agreement with the
immunohistochemistry staining results, qRT-PCR
revealed that ERRa expression in the injury-XCT790
group was signiﬁcantly decreased compared with the
injury-saline group on day 1, 3 and 7 after SCI (Fig. 4A).
Moreover, the protein levels of ERRa in the injury-
XCT790 group were also signiﬁcantly lower throughout
the experiment (Fig. 3A).sion in the ventral horn of the injured spinal cord site according to H&E
epresentative micrographs of the gray matter ventral horn showing
sham group, the injury-saline group and the injury-XCT790 group at
CT790 group, 200 magniﬁcation). (G) Spatiotemporal comparison of
matory cell inﬁltration; h arrow: hemorrhage; v arrow: vacuolation. The
ce of the diﬀerences between groups at speciﬁc time points were
< 0.05, ⁄⁄p< 0.01 vs. the sham group; #p< 0.05, ##p< 0.01 vs. the
Fig. 2. Eﬀects of XCT790 on the cavity formation in the lesion epicenter of the injured spinal cord at 7 days after SCI. Representative micrographs
of the transverse section showing diﬀerences in cavity areas among the sham group, the injury-saline group and the injury-XCT790 group at 7 days
post-injury (A: Sham group; B: injury-saline group; C: injury-XCT790 group, 50 magniﬁcation). (D) Graphical representation showing a statistically
signiﬁcant increase in cavity areas following XCT790 injection. f arrow: cavity formation. The results are expressed as mean ± SD of ﬁve animals
per group. Signiﬁcance of the diﬀerences between the injury-saline group and the injury-XCT790 group were analyzed by Student’s t test
(⁄⁄p< 0.01 vs. the injury-saline group). Scale bar = 400 lm.
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1a, VEGF and Ang-2 after SCI
We used Western blot analysis to evaluate changes in
PGC-1a, VEGF and Ang-2 protein levels at the lesion
site. Additionally, qRT-PCR was applied to detect
expression of these genes at various time points after
SCI, from 24 h to 7 days. The western blot results
revealed that PGC-1a protein expression in injury-
saline-treated animals was signiﬁcantly lower at 1 day
after SCI, and then was increased to the peak at
3 days after SCI, followed by a remarkable decline at
7 days after SCI compared to sham animals. Data
analysis indicates that PGC-1a protein expression in the
injury-XCT790 group was not repressed as compared to
that in the injury-saline group at 1 day after trauma but
was reduced by 3 and 7 days after SCI (Fig. 3B).
Moreover, qRT-PCR analyses revealed that PGC-1a
gene expression between the injury-XCT790 group and
the injury-saline group had no signiﬁcant statistical
diﬀerence at all time points (Fig. 4B). We also found
that SCI induced a signiﬁcant increase in VEGF protein
levels 24 h after SCI, relative to sham animals that
remain elevated until 7 days post-injury. Nevertheless,
compared with the injury-saline group, inhibition of
ERRa in the injury-XCT790 group signiﬁcantly reverted
the upregulation of VEGF induced by the injury at 1 day
post injury and repressed expression even more at 3
and 7 days (Fig. 3C). This signiﬁcant reduction in VEGF
in the injury-XCT790 group was further validated by the
qRT-PCR results (Fig. 4C). It is worth noting that a
marked decrease in Ang-2 protein levels was observed
1 day after SCI in the injury-saline group. However,starting on day 3 after SCI, Ang-2 levels gradually
began to increase over time. Quantitative analysis of
Ang-2 levels in both the injury-XCT790 and injury-saline
groups indicated that the decrease in Ang-2 protein
levels was signiﬁcant at all time points (Fig. 3D). These
results were further conﬁrmed by those of the qRT-PCR
analysis (Fig. 4D).
Reduced ERRa expression decreased vascular
density and endothelial cell proliferation after SCI
To determine whether SCI was responsible for the
change in vascular density and whether the spinal cord
vasculature was actively proliferating after SCI in the
various groups, tissue slices of 1, 3 and 7 days after
SCI were stained with antibodies against the endothelial
cell marker RECA-1 and against a marker of
proliferating cells, PCNA. RECA-1 immunoﬂuorescence
revealed a signiﬁcant decrease in the number of vessels
at 24 h post-injury compared with those of the uninjured
(sham) animals. At 3 and 7 days after SCI, the density
of RECA-1-labeled blood vessels in the injury-XCT790
and injury-saline groups gradually increased and
reached a peak 7 days after SCI (Fig. 5B, C). However,
signiﬁcant diﬀerences between the injury-XCT790 and
injury-saline groups were observed at 1, 3 and 7 days
after SCI (Fig. 5D). We quantiﬁed the number of
proliferating endothelial cells (RECA-1/PCNA) to assess
angiogenesis (Fig. 6A). Uninjured spinal cord tissue
showed relatively low basal levels of endothelial cell
proliferation. However, sections from the injury-saline
group 3 and 7 days after SCI exhibited a signiﬁcant
number of proliferating endothelial cells in angiogenic
Fig. 3. Eﬀects of XCT790 on the protein expression of ERRa, PGC-1a, VEGF and Ang-2 at 1, 3 and 7 days after SCI. Western blot bands show the
protein expression levels of ERRa, PGC-1a, VEGF and Ang-2 at various time points after SCI in each group (n= 5). (A–D) Comparison of ERRa,
PGC-1a, VEGF and Ang-2 protein expression among the three groups (n= 5) at various time points after SCI. Data represent mean ± SD, and
signiﬁcance of the diﬀerences between groups at speciﬁc time points were evaluated using the ANOVA followed by the Newman–Keuls post hoc
test (⁄p< 0.05, ⁄⁄p< 0.01 vs. the sham group; #p< 0.05, ##p< 0.01 vs. the injury-saline group).
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number of proliferating endothelial cells compared with
those of the injury-saline group 3 and 7 days after SCI
(Fig. 6B).DISCUSSION
Traumatic SCI causes an immediate loss of vascular
supply and initiates a multifaceted response to injury. A
loss of blood vessels causes cell death and a loss of
tissue integrity. Therefore, early reconstruction of blood
vessels could support the repair of the injured spinal
cord (Ning et al., 2013). Angiogenesis is a highly synchro-
nized and tightly regulated process that involves endothe-
lial cell proliferation, migration, vascular tubule formation
and cell survival, and it requires stringent orchestration
by the tissue being vascularized (Fong, 2008; Sapieha,
2012).To date, few studies have revealed a role for ERRa in
the process of angiogenesis after SCI. In fact, to our
knowledge, this is the ﬁrst study to investigate whether
XCT790 antagonizes ERRa expression and its eﬀects
on PGC-1a, VEGF, and Ang-2 expression, vascular
density and endothelial cell proliferation in an
experimental rat model of traumatic SCI. Taken
together, the present results indicate that XCT790
injection signiﬁcantly suppressed expression of ERRa,
thus down-regulating expression of VEGF and Ang-2,
decreasing vessel density and reducing endothelial cell
proliferation. An attenuation of ERRa accumulation
might inhibit angiogenesis following rat SCI compared
with changes observed in the injury-saline group.
ERRa has shown to function as a regulator of
oxidative metabolism across a wide range of tissues
(Huss et al., 2004; Bonnelye et al., 2007; Stein et al.,
2008; Xue et al., 2009; Ndubuizu et al., 2010). Our study
Fig. 4. Eﬀects of XCT790 on the expression of ERRa, PGC-1a, VEGF and Ang-2 mRNA at 1, 3 and 7 days after SCI. (A–D) Comparison of ERRa
mRNA, PGC-1a mRNA, VEGF mRNA and Ang-2 mRNA expression among the three groups (n= 5) at various time points after SCI. Data
represent mean ± SD, and signiﬁcance of the diﬀerences between groups at speciﬁc time points were evaluated using the ANOVA followed by the
Newman–Keuls post hoc test (⁄p< 0.05, ⁄⁄p< 0.01 vs. the sham group; #p< 0.05, ##p< 0.01 vs. the injury-saline group).
Fig. 5. Eﬀects of XCT790 on vascular density in the injured spinal cord site at 1, 3 and 7 days after SCI. Representative images taken from the
ventral horn of the spinal cord at 7 days post-injury. The vessels were labeled with RECA-1 (A: Sham group; B: injury-saline group; C: injury-
XCT790 group, 200 magniﬁcation). (D) Spatiotemporal comparison of RECA-1 labeled vascular counts among the three groups. Data represent
mean ± SD of ﬁve animals per group, and signiﬁcance of the diﬀerences between groups at speciﬁc time points were evaluated using the ANOVA
followed by the Newman–Keuls post hoc test (⁄p< 0.05, ⁄⁄p< 0.01 vs. the sham group; #p< 0.05, ##p< 0.01 vs. the injury-saline group). Scale
bar = 100 lm.
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Fig. 6. Eﬀects of XCT790 on vascular endothelial cell proliferation in the injured spinal cord site at 1, 3 and 7 days after SCI. (A) Representative
PCNA/RECA-1 double-labeled images (RECA-1, red; PCNA, green; DAPI, blue, 200 magniﬁcation) taken from the ventral horn of the spinal cord
at 7 days post-injury. White arrowheads indicate the merged labeling, which represents vascular proliferation. (B) Spatiotemporal comparison of
proliferative vascular endothelial cells among the three groups. Data represent mean ± SD of ﬁve animals per group, and signiﬁcance of the
diﬀerences between groups at speciﬁc time points were evaluated using the ANOVA followed by the Newman–Keuls post hoc test (⁄p< 0.05,
⁄⁄p< 0.01 vs. the sham group; #p< 0.05, ##p< 0.01 vs. the injury-saline group). Scale bar = 100 lm.
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spinal cord gray matter. Estrogen-related receptors
(ERRs) are a family of orphan nuclear hormone receptors
initially identiﬁed based on their homology to the estrogen
receptor ERa. ERa and ERRa bind to and activate tran-
scription through the classical estrogen response element
(ERE) (Vanacker et al., 1999). A recent paper has
demonstrated that ERa was up-regulated after SCI and
the activation of this receptor mediates some of the func-
tional locomotor recovery and the extent of white matter
spared tissue (Mosquera et al., 2014). According to the
histopathological and protein expression results, we
found that the number of ERRa-positive cells was lower,
but the protein expression of ERRa was higher 3 days
after SCI and similar 7 days after SCI. We surmise that
the primary insult after SCI caused immediate tissue
structural destruction, thereby reducing the number of
cells that express ERRa. ERRa is not a constitutively
active receptor and that transformation into an active form
is favored by binding to PGC-1a. High metabolic needs
after SCI regulated the expression of PGC-1a and thus
may aﬀect the activity of ERRa (Schreiber et al., 2003).
Subsequently, a cascade of biochemical and cellular pro-
cesses was involved in the spinal cord secondary injury
that triggered an upregulation of the ERRa protein
expression to support the high metabolic needs that char-
acterize highly proliferative endothelial cells. The con-
comitant induction of angiogenesis by ERRa, therefore,serves to supplement the limited oxygen and nutrient sup-
ply provided by existing vessels (Stein et al., 2009). Oxy-
gen and nutrient supply is conducive to tissue repair and
minimizing nerve damage after SCI. With the gradual
increase of karyolysis and vacuolation, the number of
ERRa-positive cells and the protein expression of ERRa
declined 7 days after SCI. Further research is required
to elucidate the mechanism underlying the ERRa activa-
tion and identify which cells from the CNS express ERRa.
XCT790 signiﬁcantly repressed the expression of ERRa,
thereby decreasing the metabolic rate and cellular oxygen
supply, which ultimately resulted in an attenuation of cel-
lular repair. In agreement with the IHC staining results,
the expression of ERRa mRNA and protein decreased
24 h after SCI, increased to peak levels on day 3, and
dropped on day 7. Our results also demonstrated that
XCT790 intervention signiﬁcantly repressed the expres-
sion of ERRa protein and mRNA throughout the whole
period.
PGC-1a is dramatically induced by nutrient and oxygen
deprivation and, in turn, regulates a varied suite of genes
involved in the coordination of neovascularization (Arany
et al., 2008). PGC-1a is highly versatile and has the ability
to co-activate many diﬀerent transcriptional factors, includ-
ing nuclear respiratory factors (NRF-1 and NRF-2), estro-
gen-related receptor-a, Gabpa/b, PPARs, and the thyroid
hormone receptor (Zheng et al., 2010). PGC-1a interacts
directly with the basal transcriptional machinery and also
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acetylase p300, to open chromatin and facilitate transcrip-
tion (Shoag and Arany, 2010). The addition of PGC-1a to
the orphan nuclear receptor ERRa led to an eightfold
induction of luciferase activity (Arany et al., 2008). VEGF
and Ang-2 was induced in muscle creatine kinase–PGC-
1a transgenic animals (Arany et al., 2008). PGC-1a
coactivates ERRa on a number of sites found both in the
promoter and a novel conserved enhancer located in the
ﬁrst intron of the VEGF gene as demonstrated by chromat-
in immunoprecipitation assays (Shoag and Arany, 2010).
Consistent with the ability of PGC-1a to induce ERRa
activity and expression, PGC-1a and ERRa show similar
spatial and temporal expression patterns in vivo (Herzog
et al., 2006). Previous research has shown that ERRa
can function as a speciﬁc molecular repressor of PGC-1a
activity and can dramatically and speciﬁcally repress
PGC-1a transcriptional activity (Ichida et al., 2002). Recent
studies have found that ERRa partially regulates PGC-1a
expression and coordinates with PGC-1a to mediate mito-
chondrial biogenesis (Handschin et al., 2003; Wang et al.,
2010). In the present study, we observed that the injury-
saline groups exhibited a similar change in PGC-1a and
ERRa expression after acute SCI. However, inhibition of
ERRawas not able to signiﬁcantly repress PGC-1a protein
and mRNA expression, compared with those of the injury-
saline group.
Angiogenesis and neurogenesis that take place in the
secondary and chronic phase after SCI and neuronal
protection that is impaired in the acute phase post-injury
(Herrera et al., 2009). VEGF can improve microcirculation
during early stages of SCI and regenerate blood vessels
during the late reconstruction stage of SCI via angio-
genesis (Herrera et al., 2009; Zhou et al., 2013; Liu
et al., 2014). Moreover, some research has shown
the neuroprotective eﬀect of VEGF in attenuating axonal
degradation and leads to better locomotor recovery fol-
lowing SCI (Herrera et al., 2009; Liu et al., 2010;
Yamaya et al., 2014). The induction in VEGF expression
was mediated, at least in part, by activation of the ERR
pathway (Zhang et al. (2011)). It is likely that ERRa is
able to activate the VEGF promoter directly through the
ERRE (Stein et al., 2009). Spiegleman and colleagues
examined the murine VEGF promoter to show that the
induction of angiogenesis is a result of direct transcription-
al regulation of VEGF by ERRa (Arany et al., 2008). In our
present study, VEGF was present at low levels in normal
spinal cord tissue; SCI induced a signiﬁcant elevation in
expression until day 7, with peak expression levels
reached 24 h following SCI. However, XCT790 injection
dramatically reduced the expression of VEGF throughout
the course of recovery. The expression proﬁles of the
ERRa and VEGF proteins and mRNAs are very similar
in the injury groups suggesting the induction of angio-
genesis is a result of direct transcriptional regulation of
VEGF by ERRa after SCI. In the injured CNS, VEGF pre-
dominantly binds to the tyrosine kinase receptor ﬂk-1
(KDR/VEGF-R2) that is expressed on the vascular
endothelium and some neurons and by triggering the
mitotic and migratory processes necessary for angio-
genesis (Krum et al., 2008). Some research has shownthat VEGF and its receptor mRNAs and proteins are
induced and slightly upregulated within 1 day in rats with
a contusion injury and persisted for at least 14 days
(Skold et al., 2000; Choi et al., 2007). Hence, we should
further explore the eﬀect of ERRa on VEGF receptors in
our next research.
Ang-2 can be induced mainly by COX-2 enzymatic
activity and is expressed by endothelial cells at sites of
active angiogenesis (Pichiule et al., 2004; Ng et al.,
2011). Upon release from endothelial cells, Ang-2 exerts
autocrine and paracrine eﬀects on the Tie-2 receptor,
thereby antagonizing Ang-1’s eﬀect on vascular integrity
in injured spinal cords (Durham-Lee et al., 2012). A suﬃ-
cient level of VEGF is present after endothelial cell
growth, proliferation, and Ang-2-induced angiogenic
sprouting, which leads to angiogenesis. Recent research
found that Ang-2 mRNA and protein levels are up-regulated
up to 10 weeks after SCI, which may underlie the early
angiogenic response following the loss of blood vessels
that occurs within 3–7 days (Ritz et al., 2010; Durham-
Lee et al., 2012). Previous studies have shown that
Ang-2 can be induced by the adenoviral delivery of
PGC-1a to the primary skeletal muscle (Arany et al.,
2008). However, this study did not address whether
ERRa inhibition aﬀected the expression of Ang-2. Our
research found that Ang-2 mRNA and protein levels sig-
niﬁcantly decreased 1 day after SCI, then rapidly
increased until day 7. Inhibition of ERRa expression sig-
niﬁcantly decreased the mRNA and protein levels of
Ang-2 throughout the whole period. The expression pro-
ﬁle of the ERRa, VEGF and Ang-2 proteins and mRNAs
are very similar in the injury groups, the mechanism by
which ERRa and/or VEGF regulate the expression of
Ang-2 and Tie-2 after SCI should be further probed.
Most endothelial cells undergo oncosis and death
during the ﬁrst 24 h after SCI, which can largely be
attributed to the initial mechanical damage (Casella
et al., 2006). Subsequently, vessel density continued to
decrease until the next day, with little or no observable
vessels at the lesion epicenter (Casella et al., 2002).
Robust angiogenesis, which results in increasing vascular
density, was observed as early as 3 days after SCI and
persisted as long as 1 week after SCI, with maximal
endothelial cell proliferation observed 7 days post-injury
(Loy et al., 2002; Figley et al., 2014). Our ﬁndings were
consistent with other research in the ﬁeld, demonstrating
that signiﬁcant angiogenesis occurred between 3 and
7 days after SCI. XCT790 decreased vascular density
and endothelial cell proliferation, thereby signiﬁcantly
inhibiting angiogenesis at 3 and 7 days after SCI.
CONCLUSION
XCT790 signiﬁcantly inhibited the expression of ERRa,
resulting in a decrease in VEGF and Ang-2 expression
and a reduction in the vascular density and endothelial
cell proliferation in a rat traumatic SCI model. ERRa
was also involved in mediating angiogenesis after SCI in
this model.
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